leisure time -WSS

leisure time

author：hotspot 2025-09-29 00:39:04 - browse：18964

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Padmanee Sharma of MD Anderson at center of lawsuit over credit

leisure time

WSS

340B reform proposal comes out of Senate working group

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

340B reform proposal comes out of Senate working group

Global cancer cases to surge 77% by 2050, WHO report says

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

What’s missing from the debate over nursing home staff minimums

hotspot

leisure time

explore

In age of alternative facts, a scholarly course on calling out crap

Padmanee Sharma of MD Anderson at center of lawsuit over credit

How to save PrEP access — and even expand it

Bernie brings in new pharma CEOs to talk drug prices

In Memoriam: Notable people who died in 2023

What’s missing from the debate over nursing home staff minimums

In age of alternative facts, a scholarly course on calling out crap

Manchin plays down potential 3rd

After affirmative action ruling, medical educators look to 'holistic review'

Johnson & Johnson sues to stop Medicare negotiation

hotspot

ER docs worry over extreme heat as a 'mass casualty event'

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

AstraZeneca stays mum on Medicare drug pricing negotiations

Johnson & Johnson sues to stop Medicare negotiation

Why CTE doesn’t keep Americans from enjoying the Super Bowl

leisure time

leisure time

leisure time

hotspot